Cancer Incidence and Mortality for Clinton County, 2012-2016

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 499.0 507.5 487.3-528.3 264.2 563.7 532.9-595.9 234.8 469.0 441.6-497.8 162.6 166.2 154.8-178.2 89.0 201.8 183.0-222.0 73.6 140.2 126.0-155.7
Oral cavity and pharynx 13.0 12.8 9.8-16.5 8.8 17.7 12.8-24.1 4.2 7.8 4.8-12.2 2.6 2.7 1.4-4.7 1.6 3.3 1.4-6.8 1.0 1.8 0.6-4.7
Esophagus 6.8 6.8 4.7-9.7 5.8 12.4 8.2-18.2 1.0 2.0 0.6-5.0 5.0 4.9 3.1-7.3 4.0 8.3 5.0-13.1 1.0 2.0 0.6-5.0
Stomach 6.4 6.6 4.5-9.4 4.4 9.7 6.0-15.0 2.0 4.0 1.9-7.8 2.6 2.7 1.4-4.7 2.2 4.8 2.3-8.9 0.4 0.9 0.1-3.4
Colorectal 37.8 39.7 34.1-45.9 19.6 43.5 35.1-53.3 18.2 36.0 28.7-44.7 11.6 12.0 9.1-15.6 7.0 16.0 11.0-22.5 4.6 8.5 5.3-13.0
Colon excluding rectum 28.6 29.9 25.1-35.4 14.2 31.8 24.7-40.4 14.4 27.8 21.6-35.3 9.4 9.7 7.1-13.0 5.4 12.1 7.9-17.7 4.0 7.3 4.4-11.6
Rectum & rectosigmoid 9.2 9.8 7.1-13.2 5.4 11.6 7.6-17.2 3.8 8.2 4.8-13.3 2.2 2.3 1.1-4.2 1.6 4.0 1.7-7.9 0.6 1.2 0.2-3.9
Liver / intrahepatic bile duct 7.6 7.1 5.0-9.9 5.8 11.7 7.7-17.1 1.8 3.2 1.4-6.4 5.8 5.6 3.8-8.2 4.0 8.4 5.0-13.2 1.8 3.4 1.5-6.8
Pancreas 14.0 13.7 10.7-17.5 7.4 15.0 10.5-20.9 6.6 12.1 8.3-17.2 11.0 10.8 8.1-14.2 5.6 11.5 7.6-17.0 5.4 9.6 6.3-14.3
Larynx 5.6 5.3 3.5-7.8 4.6 9.2 5.7-14.1 1.0 1.9 0.6-4.8 0.2 0.3 0.0-1.4 0.0 0.0 0.0-1.9 0.2 0.5 0.0-3.0
Lung and bronchus 91.0 91.3 82.9-100.3 49.0 105.5 92.4-120.1 42.0 80.3 69.6-92.3 49.6 49.9 43.8-56.7 26.6 57.8 48.2-68.9 23.0 44.6 36.7-53.9
Melanoma of the skin 24.6 25.6 21.2-30.7 13.4 27.7 21.3-35.5 11.2 24.3 18.1-32.0 1.8 1.9 0.9-3.8 1.4 3.6 1.4-7.4 0.4 0.8 0.1-3.3
Female breast             52.2 106.2 93.2-120.6             8.2 15.7 11.2-21.7
Cervix uteri             2.4 7.4 3.7-13.0             2.0 4.8 2.2-9.2
Corpus uterus and NOS             14.6 27.5 21.4-34.9             2.0 3.9 1.8-7.4
Ovary             6.2 12.9 8.6-18.7             3.2 5.6 3.2-9.4
Prostate       43.8 87.2 75.7-100.0             6.4 16.2 11.0-23.0      
Testis       3.0 7.1 4.0-11.9             0.0 0.0 0.0-1.9      
Urinary bladder (incl. in situ) 25.4 25.7 21.4-30.7 20.6 45.8 37.2-55.9 4.8 8.8 5.6-13.3 4.0 4.1 2.5-6.5 2.6 6.4 3.4-11.0 1.4 2.5 1.0-5.5
Kidney and renal pelvis 24.8 25.2 20.9-30.3 16.6 34.5 27.3-43.1 8.2 16.5 11.8-22.8 4.0 4.0 2.5-6.4 3.0 6.5 3.6-11.0 1.0 1.9 0.6-4.8
Brain and other central nervous system 5.4 5.5 3.6-8.2 3.0 6.6 3.6-11.1 2.4 4.3 2.2-7.8 4.8 5.2 3.2-7.9 3.0 7.0 3.8-11.8 1.8 3.3 1.5-6.6
Thyroid 15.2 16.9 13.2-21.4 5.0 10.2 6.5-15.4 10.2 24.6 18.0-32.8 0.4 0.5 0.1-1.7 0.2 0.6 0.0-3.1 0.2 0.4 0.0-2.8
Hodgkin lymphoma 3.2 3.8 2.1-6.2 1.4 3.1 1.2-6.6 1.8 4.5 2.0-8.7 0.0 0.0 0.0-1.0 0.0 0.0 0.0-1.9 0.0 0.0 0.0-2.0
Non-Hodgkin lymphomas 25.0 25.7 21.3-30.8 13.4 30.1 23.1-38.5 11.6 22.9 17.2-29.9 7.4 7.7 5.4-10.7 4.4 11.2 6.9-17.0 3.0 5.7 3.1-9.7
Myeloma 9.0 8.9 6.5-12.1 5.4 10.8 7.0-16.0 3.6 7.4 4.3-11.9 3.4 3.5 2.0-5.7 2.2 5.4 2.7-9.8 1.2 2.3 0.8-5.3
Leukemias 15.2 15.8 12.4-20.0 9.2 20.9 15.1-28.1 6.0 11.1 7.4-16.1 5.0 5.1 3.3-7.7 3.2 7.4 4.2-12.3 1.8 3.5 1.5-7.0

Notes

  • Incidence data are provisional, November 2018.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.